MedTrace Logo

Emdogain and Straumann Bone Ceramic in Infrabony Defects

NCT00906776 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2016-05-09

Study results available
· View outcomes & findings →

Summary

Randomised, controlled, clinical study to compare the effect of the combination of bone ceramic and enamel matrix proteins (test) versus autogenous bone graft alone (control) in the treatment of deep-wide intrabony defects

Conditions

  • Periodontitis

Interventions

DEVICE

Emdogain PLUS

Emdogain treatment followed by Straumann Bone Ceramic application during periodontal surgery

DEVICE

Autogenous bone

Autogenous bone application during periodontal surgery

Sponsors & Collaborators

  • Institut Straumann AG

    lead INDUSTRY

Principal Investigators

  • Philippe Bouchard, Prof · Rotschild Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00906776 on ClinicalTrials.gov